BioRestorative Therapies, Inc. (BRTX)
NASDAQ: BRTX · Real-Time Price · USD
0.3400
+0.0100 (3.03%)
Jul 15, 2026, 10:53 AM EDT - Market open
BioRestorative Therapies Employees
As of December 31, 2025, BioRestorative Therapies had 14 total employees, including 13 full-time and 1 part-time employees. The number of employees increased by 3 or 27.27% compared to the previous year.
Employees
14
Change (1Y)
3
Growth (1Y)
27.27%
Revenue / Employee
$25,562
Profits / Employee
-$789,756
Market Cap
8.66M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 14 | 3 | 27.27% | 13 | 1 |
| Dec 31, 2024 | 11 | 0 | - | 11 | 0 |
| Dec 31, 2023 | 11 | 1 | 10.00% | 11 | 0 |
| Dec 31, 2022 | 10 | 3 | 42.86% | 10 | 0 |
| Dec 31, 2021 | 7 | 2 | 40.00% | 7 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Curis | 24 |
| Imunon | 20 |
| TransCode Therapeutics | 12 |
| MetaVia | 8 |
| Aprea Therapeutics | 8 |
| Immuron | 7 |
| Quoin Pharmaceuticals | 6 |
| Cadrenal Therapeutics | 5 |
BRTX News
- 20 days ago - BioRestorative Therapies completes manufacturing for BRTX-100 - TheFly
- 20 days ago - BioRestorative Therapies Announces Completion of BRTX-100 Phase 2 Manufacturing, Highlighting Integrated Regenerative Biologics Platform - GlobeNewsWire
- 20 days ago - BioRestorative Therapies Slides: Corporate presentation - Filings
- 27 days ago - BioRestorative Therapies appoints Smith as VP of Biocosmeceuticals Division - TheFly
- 27 days ago - BioRestorative Therapies Strengthens Leadership with Appointment of Healthcare Executive Zachary Smith as Vice President of Biocosmeceuticals Division to Accelerate Commercial Expansion and Strategic Growth - GlobeNewsWire
- 6 weeks ago - BioRestorative Therapies Slides: Corporate presentation - Filings
- 7 weeks ago - BioRestorative Therapies shareholder Kaos Capital acquires 4.9% stake - TheFly
- 7 weeks ago - Kaos Capital Announces Acquisition of 4.9% Stake in BioRestorative Therapies (NASDAQ: BRTX) - PRNewsWire